yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q47118783-4E6A8D7E-DBC2-4974-8A84-F76BB12E600E
Q47118783-4E6A8D7E-DBC2-4974-8A84-F76BB12E600E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47118783-4E6A8D7E-DBC2-4974-8A84-F76BB12E600E
Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab.
P2860
Q47118783-4E6A8D7E-DBC2-4974-8A84-F76BB12E600E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47118783-4E6A8D7E-DBC2-4974-8A84-F76BB12E600E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
32d8a16f0ef5ab5b4e07e06649129ec783fd4739
P2860
Relationship of Body Mass Index to Clinical Outcomes after Infliximab Therapy in Patients with Crohn's Disease.